Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Brachytherapy|September 21, 2025
American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statementAurelie Garant, Craig E Grossman, Martin T King, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2021
Brachial Plexus Tolerance to Single-Session SABR in a Pig ModelBrian Hrycushko, Albert J van der Kogel, Lauren Phillips, et al.
Journal of Neurosurgery. Spine|March 5, 2016
Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure studyJonathan E Leeman, Mark Bilsky, Ilya Laufer, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2019
Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation TherapyBrian Hrycushko, Albert J van der Kogel, Lauren Phillips, et al.
Brachytherapy|July 20, 2023
Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicatorHugh H C Lee, Tsuicheng D Chiu, Brian Hrycushko, et al.
Brachytherapy|February 26, 2013
Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patientsMichael R Folkert, Gil'ad N Cohen, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2020
Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver MetastasesMichael R Folkert, Jeffrey J Meyer, Todd A Aguilera, et al.
American Journal of Clinical Oncology|July 23, 2020
Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal CancerAndrew J Leiker, Chiachien J Wang, Nina N Sanford, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 5, 2017
Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trialsRyan T Jones, Nima Hassan Rezaeian, Neil B Desai, et al.
Pageof 7